Anzeige
Mehr »
Montag, 27.10.2025 - Börsentäglich über 12.000 News
Automatisierung ist das neue Gold: Telescope Innovations erfindet Entdeckung von Medizin & Materialien neu!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E2E9 | ISIN: US09060C5076 | Ticker-Symbol: BJO0
NASDAQ
24.10.25 | 20:13
0,789 US-Dollar
0,00 % 0,000
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
BIO-KEY INTERNATIONAL INC Chart 1 Jahr
5-Tage-Chart
BIO-KEY INTERNATIONAL INC 5-Tage-Chart
GlobeNewswire (Europe)
150 Leser
Artikel bewerten:
(0)

BIO-key International, Inc.: BIO-key International and IT2Trust Partner to Strengthen IAM and Biometric Security Across the Nordic Region of Denmark, Sweden, Norway and Finland

COPENHAGEN, Denmark and HOLMDEL, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovator in biometric authentication and Identity and Access Management (IAM) solutions, today announced a new partnership with IT2Trust, one of Scandinavia's most established distributors of IT security and networking solutions.

This collaboration marks a significant step in BIO-key's expansion across the Nordic market. IT2Trust's deep technical expertise and strong regional presence will help deliver BIO-key's GDPR-compliant and scalable IAM technologies to enterprises and public sector organizations across Denmark, Sweden, Norway, and Finland-strengthening identity protection, ensuring regulatory compliance, and advancing secure digital transformation.

Under the agreement, IT2Trust will distribute and support BIO-key's full portfolio of IAM and biometric authentication products, including:

  • PortalGuard® - a comprehensive IAM platform supporting MFA, SSO, and centralized access management
  • Passkey:YOU - a FIDO2-compliant passwordless solution
  • PIN:You - a secure, tokenless, user-friendly PIN-based authentication method
  • WEB-key - a proven biometric engine for strong authentication
  • Identity-Bound Biometrics (IBB) - binding access to the individual, not the device
  • Certified biometric scanners including PIV-Pro and EcoID III

"BIO-key's proven identity and access management solutions perfectly complement our mission to deliver secure and innovative technologies to the Nordic market. We're excited to bring their expertise to our customers and partners." said Anders Enemark Mortensen, Founder & Marketing Director, IT2Trust.

"This collaboration with IT2Trust is opening doors across the Nordics. Their trusted distribution and on-the-ground guidance, paired with BIO-key's technology, are exactly what government teams are asking for," said Ana Marques, Territory Sales Director, BIO-key International.

"Our partnership with IT2Trust is a natural step in BIO-key's European growth strategy. Together, we're bringing the next generation of identity and access management to the Nordic market-combining local market knowledge with global innovation to help organizations protect their people, data, and digital future," added Alex Rocha, Managing Director, BIO-key International (EMEA)

About IT2Trust (www.it2trust.com)
IT2Trust is one of Scandinavia's leading value-added distributors of IT security and network solutions, delivering next-generation technologies and trusted cybersecurity expertise across the Nordic region. Partnering with top global vendors, IT2Trust provides consulting, training, and support services to enterprises and public organizations seeking to strengthen their digital resilience and compliance posture.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements, whether as a result of new information, future events, or otherwise.

Engage with BIO-key Corporate
Facebook: https://www.facebook.com/BIOkeyInternational/
LinkedIn: https://www.linkedin.com/company/bio-key-international
X: @BIOkeyIntl
X - Investors: @BIO_keyIR
StockTwits: @BIO_keyIR
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800

© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.